The Feasibility of Multispectral Optoacoustic Tomography in Different Diseases
Launched by UNIVERSITY MEDICAL CENTER GRONINGEN · Dec 13, 2024
Trial Information
Current as of June 05, 2025
Completed
Keywords
ClinConnect Summary
Optoacoustic imaging is a novel imaging method that is based on the optoacoustic effect, first described by Alexander Graham Bell in 1880. When biological tissue is illuminated with an ultrashort laser pulse, tissue chromophores absorb laser light and form pressure transient waves as a result of thermoelastic expansion. These optoacoustic or photoacoustic waves can be detected by wideband ultrasonic transducers around the tissue. Optoacoustic imaging is unique as it resolves optical contrast, but the resolution obeys the rules of ultrasonic diffraction; scattering of the ultrasonic signal i...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- * Patients with the following diseases will be included:
- • 1. Morbus Sjögren,
- • 2. A superficially located malignant tumor \< 5 centimeter beneath the skin
- • 3. (Peripheral) arterial disease
- • Age ≥ 18 years;
- Exclusion Criteria:
- • Patients with disease localizations or manifestations that do not enable good coupling between the optoacoustic probe and the skin, as decided by the researchers;
- • Medical or psychiatric conditions that compromise the patient's ability to give informed consent.
- • Pregnant women. Women of childbearing potential need to undergo a pregnancy test before participation.
About University Medical Center Groningen
University Medical Center Groningen (UMCG) is a leading academic medical center in the Netherlands, renowned for its commitment to innovative research, high-quality patient care, and extensive education in the medical field. As a prominent sponsor of clinical trials, UMCG leverages its multidisciplinary expertise and state-of-the-art facilities to advance medical knowledge and improve therapeutic outcomes. The center fosters collaboration among researchers, healthcare professionals, and industry partners, aiming to translate scientific discoveries into effective treatments that enhance patient health and well-being. With a focus on ethical standards and regulatory compliance, UMCG is dedicated to conducting clinical trials that contribute to the advancement of medicine and the betterment of society.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Groningen, , Netherlands
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported